EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1)

Brian Na iD, C Dustin Rubinstein iD, Jennifer J Meudt, Fausto J Rodriguez iD, Brent P Lehman iD, Jamie L Reichert iD, Jeremie Vitte iD, Dhanansayan Shanmuganayagam iD, Marco Giovannini iD

Cancers · 09.06.2026 · 18 (12) · 1879

DOI: 10.3390/cancers18121879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 09.06.2026. Verfasst von Brian Na und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tower Cancer Research Foundation, NIH HHS, Matthew Larson Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Among CNS malignancies arising in infancy, ATRT stands out as the most frequently diagnosed in children younger than six months. Disruption of the SMARCB1 gene underlies the overwhelming majority of cases. Progress toward effective treatment has been hampered by two persistent challenges. Current mouse models, while informative, fall short of reproducing the full clinical and biological picture of human ATRT, and their ability to predict therapeutic outcomes in patients remains uncertain. Compounding this, the rarity of the disease makes it difficult to assemble patient cohorts of sufficient size for meaningful clinical trials. At the molecular level, germline loss of SMARCB1 exons 4 and 5 has emerged as a particularly penetrant predisposing event, with affected individuals presenting at an earlier age than those harboring other mutation types. The porcine SMARCB1 gene offers a compelling basis for translational modeling as its protein product is identical to the human ortholog at every amino acid position across isoforms, a degree of conservation that exceeds what is seen in the mouse.

Methods

Thus, we hypothesized that germline deletion of exons 4 and 5 would predispose heterozygote swine to ATRT development. In this manuscript, we describe the creation of an ATRT porcine model through a CRISPR/Cas9 mediated gene-editing approach.

Results

15 piglets were produced, two of which had confirmed SMARCB1 targeted excisions. However, none developed tumors. To induce further tumorigenicity, one pig with confirmed exons 4 and 5 excision was crossed with a pig with TP53 exon 2 truncation. In total, 11 piglets were born, of which one contained the original excision without a TP53 mutation. This piglet developed a spinal mass at the T1 level.

Conclusion

To our knowledge, this is the first ATRT porcine model ever developed and provides proof-of-concept feasibility for large animal modeling of SMARCB1-deficient rhabdoid tumors. These findings support the continued development of porcine RTPS-1 models toward preclinical application.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9pig modelrhabdoid tumors

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • Division of Neuro-Oncology, Department of Neurological Surgery, UCSF, San Francisco, CA 94143, USA.
  • Jonsson Comprehensive Cancer Center, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • Biotechnology Center, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Biomedical and Genomic Research Group, Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Division of Neuropathology, Department of Pathology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.

ORCID-Profile: Brian Na, C Dustin Rubinstein, Fausto J Rodriguez, Brent P Lehman, Jamie L Reichert, Jeremie Vitte, Dhanansayan Shanmuganayagam, Marco Giovannini

Förderung

  • Tower Cancer Research Foundation
  • NIH HHS
  • Matthew Larson Foundation
  • University of Wisconsin-Madison
  • Neurofibromatosis Network
  • NF North Central
  • NF Team
  • Links for Lauren

Zitieren

APA

Na, B., Rubinstein, C. D., Meudt, J. J., Rodriguez, F. J., Lehman, B. P., Reichert, J. L., Vitte, J., Shanmuganayagam, D., & Giovannini, M. (2026). Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1). Cancers, 18(12), 1879. https://doi.org/10.3390/cancers18121879

Vancouver

Na B, Rubinstein CD, Meudt JJ, Rodriguez FJ, Lehman BP, Reichert JL, et al. Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1). Cancers. 2026;18(12):1879. doi:10.3390/cancers18121879

BibTeX
@article{Na2026,
  author = {Na, Brian and Rubinstein, C Dustin and Meudt, Jennifer J and Rodriguez, Fausto J and Lehman, Brent P and Reichert, Jamie L and Vitte, Jeremie and Shanmuganayagam, Dhanansayan and Giovannini, Marco},
  title = {Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1)},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1879},
  doi = {10.3390/cancers18121879}
}
Kostenlos starten →